Language:
English
繁體中文
Help
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Pharmacogenomics in Drug Discovery and Development
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Pharmacogenomics in Drug Discovery and Development/ edited by Qing Yan.
other author:
Yan, Qing.
Description:
XIV, 616 p. 54 illus., 47 illus. in color.online resource. :
Contained By:
Springer Nature eBook
Subject:
Medicinal Chemistry. -
Online resource:
https://doi.org/10.1007/978-1-0716-2573-6
ISBN:
9781071625736
Pharmacogenomics in Drug Discovery and Development
Pharmacogenomics in Drug Discovery and Development
[electronic resource] /edited by Qing Yan. - 3rd ed. 2022. - XIV, 616 p. 54 illus., 47 illus. in color.online resource. - Methods in Molecular Biology,25471940-6029 ;. - Methods in Molecular Biology,2540.
Target Discovery for Drug Development Using Mendelian Randomization -- Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics -- Pharmacogenomics in Targeted Therapy and Supportive Care Therapies for Cancer -- Pharmacogenomics in Cytotoxic Chemotherapy of Cancer -- Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neuropathy -- The Yin-Yang Dynamics in Cancer Pharmacogenomics and Personalized Medicine -- Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next Generation Sequencing Data -- COVID-19 Pharmacotherapy: Drug Development, Repurposing of Drugs, and the Role of Pharmacogenomics -- Pharmacogenomics Informs Cardiovascular Pharmacotherapy -- Pharmacogenomic Screening of Patient-Specific hiPSC-Derived Cardiomyocyte Drug Candidates Using High-Throughput Calcium Imaging -- The Yin-Yang Dynamics in Cardiovascular Pharmacogenomics and Personalized Medicine -- GTPgS Assay for Measuring Agonist-Induced Desensitization of Two Human Polymorphic Alpha2B-Adrenoceptor Variants -- Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development -- Pharmacogenetics of Antipsychotic Treatment in Schizophrenia -- The Pharmacogenetic Impact on the Pharmacokinetics of ADHD Medications -- Pharmacogenetics of Addiction Therapy -- Pharmacogenomics of Opioid Treatment for Pain Management -- The Role of Pharmacogenomics in Postoperative Pain Management -- Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis -- Pharmacogenomics in Children -- Genetic Ancestry Inference for Pharmacogenomics.
This new edition offers a state-of-the-art and integrative vision of pharmacogenomics by exploring new concepts and practical methodologies focusing on disease treatments, from cancers to cardiovascular and neurodegenerative disorders and more. The collection of these theoretical and experimental approaches facilitates problem-solving by tackling the complexity of personalized drug discovery and development. Written by leading experts in their fields for the highly successful Methods in Molecular Biology series, the book aims to provide across-the-board resources to support the translation of pharmacogenomics into better individualized health care. Authoritative and up-to-date, Pharmacogenomics in Drug Discovery and Development, Third Edition aims to aid researchers in approaching the challenges in pharmacogenomics and personalized medicine with the introduction of these novel ideas and cutting-edge methodologies.
ISBN: 9781071625736
Standard No.: 10.1007/978-1-0716-2573-6doiSubjects--Topical Terms:
668872
Medicinal Chemistry.
LC Class. No.: RM300-666
Dewey Class. No.: 615
Pharmacogenomics in Drug Discovery and Development
LDR
:03821nam a22003855i 4500
001
1082873
003
DE-He213
005
20220906170419.0
007
cr nn 008mamaa
008
221228s2022 xxu| s |||| 0|eng d
020
$a
9781071625736
$9
978-1-0716-2573-6
024
7
$a
10.1007/978-1-0716-2573-6
$2
doi
035
$a
978-1-0716-2573-6
050
4
$a
RM300-666
072
7
$a
MMG
$2
bicssc
072
7
$a
MED071000
$2
bisacsh
072
7
$a
MKG
$2
thema
082
0 4
$a
615
$2
23
245
1 0
$a
Pharmacogenomics in Drug Discovery and Development
$h
[electronic resource] /
$c
edited by Qing Yan.
250
$a
3rd ed. 2022.
264
1
$a
New York, NY :
$b
Springer US :
$b
Imprint: Humana,
$c
2022.
300
$a
XIV, 616 p. 54 illus., 47 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
490
1
$a
Methods in Molecular Biology,
$x
1940-6029 ;
$v
2547
505
0
$a
Target Discovery for Drug Development Using Mendelian Randomization -- Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics -- Pharmacogenomics in Targeted Therapy and Supportive Care Therapies for Cancer -- Pharmacogenomics in Cytotoxic Chemotherapy of Cancer -- Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neuropathy -- The Yin-Yang Dynamics in Cancer Pharmacogenomics and Personalized Medicine -- Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next Generation Sequencing Data -- COVID-19 Pharmacotherapy: Drug Development, Repurposing of Drugs, and the Role of Pharmacogenomics -- Pharmacogenomics Informs Cardiovascular Pharmacotherapy -- Pharmacogenomic Screening of Patient-Specific hiPSC-Derived Cardiomyocyte Drug Candidates Using High-Throughput Calcium Imaging -- The Yin-Yang Dynamics in Cardiovascular Pharmacogenomics and Personalized Medicine -- GTPgS Assay for Measuring Agonist-Induced Desensitization of Two Human Polymorphic Alpha2B-Adrenoceptor Variants -- Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development -- Pharmacogenetics of Antipsychotic Treatment in Schizophrenia -- The Pharmacogenetic Impact on the Pharmacokinetics of ADHD Medications -- Pharmacogenetics of Addiction Therapy -- Pharmacogenomics of Opioid Treatment for Pain Management -- The Role of Pharmacogenomics in Postoperative Pain Management -- Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis -- Pharmacogenomics in Children -- Genetic Ancestry Inference for Pharmacogenomics.
520
$a
This new edition offers a state-of-the-art and integrative vision of pharmacogenomics by exploring new concepts and practical methodologies focusing on disease treatments, from cancers to cardiovascular and neurodegenerative disorders and more. The collection of these theoretical and experimental approaches facilitates problem-solving by tackling the complexity of personalized drug discovery and development. Written by leading experts in their fields for the highly successful Methods in Molecular Biology series, the book aims to provide across-the-board resources to support the translation of pharmacogenomics into better individualized health care. Authoritative and up-to-date, Pharmacogenomics in Drug Discovery and Development, Third Edition aims to aid researchers in approaching the challenges in pharmacogenomics and personalized medicine with the introduction of these novel ideas and cutting-edge methodologies.
650
2 4
$a
Medicinal Chemistry.
$3
668872
650
0
$a
Pharmacology.
$3
583819
650
0
$a
Genomics.
$3
578973
650
0
$a
Medicinal chemistry.
$3
1253747
700
1
$a
Yan, Qing.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1068929
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9781071625729
776
0 8
$i
Printed edition:
$z
9781071625743
776
0 8
$i
Printed edition:
$z
9781071625750
830
0
$a
Methods in Molecular Biology,
$x
1940-6029 ;
$v
2540
$3
1387604
856
4 0
$u
https://doi.org/10.1007/978-1-0716-2573-6
912
$a
ZDB-2-PRO
950
$a
Springer Protocols (Springer-12345)
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login